Organization
CCRT/The Caroline Foundation
6 abstracts
Abstract
The association of centromere amplification and response to trastuzumab in HER2+ metastatic breast cancer.Org: School of Biotechnology, Medical Oncology Department, CCRT/The Caroline Foundation, Galway University Hospital, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School,
Abstract
Pharmacokinetics (PK) and pharmacogenomics (PGx) of ribociclib (ribo) in Black patients with metastatic breast cancer (mBC): The LEANORA study.Org: Georgetown University Medical Center, Washington, DC, Tufts Medical Center/Tufts University, Boston, MA, National Cancer Institute/National Institutes of Health,
Abstract
Association of 18F-FDG PET characteristics and survival outcomes using whole body tumor analysis in patients (pts) with metastatic genitourinary (GU) malignancies.Org: National Cancer Institute, Vilnius, Lithuania, National Institutes of Health Division of Occupational Health and Safety, Genitourinary Malignancies Branch, CCRT/The Caroline Foundation, NCI,
Abstract
Comparison of peripheral blood markers in predicting the occurrence of immune-related adverse events in patients with metastatic genitourinary cancer treated with cabozantinib + nivolumab +/- ipilimumab.Org: Genitourinary Malignancies Branch, CCRT/The Caroline Foundation, NCI, Nihon Medi-Physics, Hospital Sírio-Libanês,
Abstract
Older adults (OA) in clinical trials: Where are they? Representation of OA in clinical trials conducted at the National Cancer Institute (NCI) Clinical Center.Org: Genitourinary Malignancies Branch, CCRT/The Caroline Foundation, NCI, Nihon Medi-Physics, Medical Oncology Service,
Abstract
Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma.Org: Center for Cancer Research, National Cancer Institute, Biostatistics and Data Management Section, OCD, NCI, NIH, Bethesda, MD, Radiology and Imaging Sciences, CCR, NCI, NIH, Bethesda, MD, Center for Interventional Oncology, Thoracic and GI Oncology Branch,